Cargando…

Can pharmaceutical pollution alter the spread of infectious disease? A case study using fluoxetine

Human activity is changing global environments at an unprecedented rate, imposing new ecological and evolutionary ramifications on wildlife dynamics, including host–parasite interactions. Here we investigate how an emerging concern of modern human activity, pharmaceutical pollution, influences the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Aulsebrook, Lucinda C., Wong, Bob B. M., Hall, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900710/
https://www.ncbi.nlm.nih.gov/pubmed/36744558
http://dx.doi.org/10.1098/rstb.2022.0010
_version_ 1784882905545179136
author Aulsebrook, Lucinda C.
Wong, Bob B. M.
Hall, Matthew D.
author_facet Aulsebrook, Lucinda C.
Wong, Bob B. M.
Hall, Matthew D.
author_sort Aulsebrook, Lucinda C.
collection PubMed
description Human activity is changing global environments at an unprecedented rate, imposing new ecological and evolutionary ramifications on wildlife dynamics, including host–parasite interactions. Here we investigate how an emerging concern of modern human activity, pharmaceutical pollution, influences the spread of disease in a population, using the water flea Daphnia magna and the bacterial pathogen Pasteuria ramosa as a model system. We found that exposure to different concentrations of fluoxetine—a widely prescribed psychoactive drug and widespread contaminant of aquatic ecosystems—affected the severity of disease experienced by an individual in a non-monotonic manner. The direction and magnitude of any effect, however, varied with both the infection outcome measured and the genotype of the pathogen. By contrast, the characteristics of unexposed animals, and thus the growth and density of susceptible hosts, were robust to fluoxetine. Using our data to parameterize an epidemiological model, we show that fluoxetine is unlikely to lead to a net increase or decrease in the likelihood of an infectious disease outbreak, as measured by a pathogen's transmission rate or basic reproductive number. Instead, any given pathogen genotype may experience a twofold change in likely fitness, but often in opposing directions. Our study demonstrates that changes in pharmaceutical pollution give rise to complex genotype-by-environment interactions in its influence of disease dynamics, with repercussions on pathogen genetic diversity and evolution. This article is part of the theme issue ‘Infectious disease ecology and evolution in a changing world’.
format Online
Article
Text
id pubmed-9900710
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-99007102023-02-08 Can pharmaceutical pollution alter the spread of infectious disease? A case study using fluoxetine Aulsebrook, Lucinda C. Wong, Bob B. M. Hall, Matthew D. Philos Trans R Soc Lond B Biol Sci Articles Human activity is changing global environments at an unprecedented rate, imposing new ecological and evolutionary ramifications on wildlife dynamics, including host–parasite interactions. Here we investigate how an emerging concern of modern human activity, pharmaceutical pollution, influences the spread of disease in a population, using the water flea Daphnia magna and the bacterial pathogen Pasteuria ramosa as a model system. We found that exposure to different concentrations of fluoxetine—a widely prescribed psychoactive drug and widespread contaminant of aquatic ecosystems—affected the severity of disease experienced by an individual in a non-monotonic manner. The direction and magnitude of any effect, however, varied with both the infection outcome measured and the genotype of the pathogen. By contrast, the characteristics of unexposed animals, and thus the growth and density of susceptible hosts, were robust to fluoxetine. Using our data to parameterize an epidemiological model, we show that fluoxetine is unlikely to lead to a net increase or decrease in the likelihood of an infectious disease outbreak, as measured by a pathogen's transmission rate or basic reproductive number. Instead, any given pathogen genotype may experience a twofold change in likely fitness, but often in opposing directions. Our study demonstrates that changes in pharmaceutical pollution give rise to complex genotype-by-environment interactions in its influence of disease dynamics, with repercussions on pathogen genetic diversity and evolution. This article is part of the theme issue ‘Infectious disease ecology and evolution in a changing world’. The Royal Society 2023-03-27 2023-02-06 /pmc/articles/PMC9900710/ /pubmed/36744558 http://dx.doi.org/10.1098/rstb.2022.0010 Text en © 2023 The Authors. https://creativecommons.org/licenses/by/4.0/Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, provided the original author and source are credited.
spellingShingle Articles
Aulsebrook, Lucinda C.
Wong, Bob B. M.
Hall, Matthew D.
Can pharmaceutical pollution alter the spread of infectious disease? A case study using fluoxetine
title Can pharmaceutical pollution alter the spread of infectious disease? A case study using fluoxetine
title_full Can pharmaceutical pollution alter the spread of infectious disease? A case study using fluoxetine
title_fullStr Can pharmaceutical pollution alter the spread of infectious disease? A case study using fluoxetine
title_full_unstemmed Can pharmaceutical pollution alter the spread of infectious disease? A case study using fluoxetine
title_short Can pharmaceutical pollution alter the spread of infectious disease? A case study using fluoxetine
title_sort can pharmaceutical pollution alter the spread of infectious disease? a case study using fluoxetine
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900710/
https://www.ncbi.nlm.nih.gov/pubmed/36744558
http://dx.doi.org/10.1098/rstb.2022.0010
work_keys_str_mv AT aulsebrooklucindac canpharmaceuticalpollutionalterthespreadofinfectiousdiseaseacasestudyusingfluoxetine
AT wongbobbm canpharmaceuticalpollutionalterthespreadofinfectiousdiseaseacasestudyusingfluoxetine
AT hallmatthewd canpharmaceuticalpollutionalterthespreadofinfectiousdiseaseacasestudyusingfluoxetine